Press Releases

May 17, 2007
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan® PDT to Treat Esophageal Dysplasia

May 4, 2007 Quarterly Conference Call
May 4, 2007 Conference Call - First Quarter 2007 Corporate Highlights and Financial Results

May 4, 2007
DUSA Pharmaceuticals Reports First Quarter 2007 Corporate Highlights and Financial Results

May 1, 2007
DUSA Pharmaceuticals, Inc. to Host First Quarter Financial Results and Corporate Highlights Conference Call

March 16, 2007
DUSA Pharmaceuticals Reports Fourth-Quarter and Year-End 2006 Financial Results

March 13, 2007
DUSA Pharmaceuticals, Inc. to Host Fourth Quarter and Full Year 2006 Financial Results and Corporate Highlights Conference Call

March 8, 2007
DUSA Pharmacueticals Reports Court Ruling Lifting Injunction Against River's Edge Sales of Generic Nicomide®

February 7, 2007
A Global Review at the American Academy of Dermatology Annual Meeting Champions Photodynamic Therapy as a First Line Treatment for Patients at Risk for Skin Cancer

January 23, 2007
International Guidelines Recommend Photodynamic Therapy as First-Line Treatment for Actinic Keratoses

January 8, 2007
DUSA Pharmaceuticals Announces Exclusive Agreement with Daewoong to Market DUSA’S LEVULAN® KERASTICK® for Photodynamic Therapy in Asian Territories